Caristo Diagnostics
PrivateLast Round
Series A
Apr 17, 2023
Total Funding Raised
$21.38M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Caristo Diagnostics is a healthtech company that develops AI-powered diagnostic and risk prediction tools for cardiovascular and vascular diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Healthcare Analytics, Medical Devices
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Caristo Diagnostics Comparables
Compare Caristo Diagnostics with similar companies based on industry and business-model similarity.
Caristo Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 17, 2023 | ||||
| Grant | Oct 20, 2018 | ||||
| Seed | Oct 20, 2018 |
Key People
Founding team and executive leadership
Caristo Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BGF | Series A |
| Oxford Science Enterprises | Seed, Series A |
| University of Oxford | Series A |
| Oxford Technology Investment Fund | Seed |
| OTIF Ventures | Series A |
| Innovate UK | Grant |
| Longwall Venture Partners | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 30% MoM, reaching 6.3K.
- Apr 14, 2026
Stephen M. Deitsch appointed as new Chief Executive Officer.
Recent news
Latest coverage and updates
- attends_eventAug 24, 2026
Caristo attended event ESC 2026 on Jul 9th '26.
- launchesJul 30, 2026
Caristo was planning to launch CaRi-Heart on Jul 1st '26.
- hiresJul 23, 2026
Caristo hires Vort.
- hiresJul 23, 2026
Caristo hires Louk.
- hiresJul 23, 2026
Caristo hired David Vort as Chief Commercial Officer on Jul 23rd '26.
Caristo Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Caristo Diagnostics's valuation, stock price, and market status.
Is Caristo Diagnostics a public or private company?
Caristo Diagnostics is a private company.
What is the current stock price of Caristo Diagnostics?
Caristo Diagnostics is a private company with no public stock price. No recent secondary market data is available.
How much is Caristo Diagnostics worth (valuation)?
Valuation information for Caristo Diagnostics is not publicly available.
Can I buy Caristo Diagnostics stock?
Caristo Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Caristo Diagnostics's last funding round?
Caristo Diagnostics's most recent funding round was Series A on April 17, 2023.
Who are the main investors in Caristo Diagnostics?
Key investors in Caristo Diagnostics include BGF, Oxford Science Enterprises.
Will Caristo Diagnostics IPO soon?
No public IPO plans have been announced for Caristo Diagnostics.
How can I track Caristo Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Caristo Diagnostics's secondary market activity and sign up for updates.